<DOC>
	<DOCNO>NCT00606801</DOCNO>
	<brief_summary>To evaluate galantamine 's effect cognitive performance abstinent cocaine user . Galantamine , medication approve treatment Alzheimer 's disease , acetylcholine esterase inhibitor . Galantamine also directly potentiate nicotine receptor . Both effect may result improved cognitive performance group subject know impaired performance various cognitive task .</brief_summary>
	<brief_title>Galantamine Effects Cognitive Function Abstinent Cocaine Users</brief_title>
	<detailed_description>Galantamine , compare placebo , improve cognitive performance abstinent cocaine user . The cognitive performance measure Stroop test 3 Cambridge Neuropsychological Test Automated Battery ( CANTAB ) test : Paired Associate Learning ( PAL ) , Delayed Pattern Recognition Memory ( PRM ) , Rapid Visual Information Processing ( RVIP ) . Performance test show impaired abstinent cocaine user , compare healthy control . Galantamine , compare placebo , associate significant change mood . Monitoring mood achieve 3 mood scale : 1 ) Center Epidemiologic Studies Depression ( CES-D ) scale , Positive Negative Affect Schedule ( PANAS ) Profile Mood States ( POMS ) . Currently study complete , Patients longer enrol . There 28 completers . This study publish .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Galantamine</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Male female , age 21 50 Fulfill criterion past cocaine dependence No cocaine use past 30 day No current dependence abuse drug alcohol No current medical problem normal ECG Not pregnant , breast feeding , Using acceptable birth control method . Current major psychiatric illness include mood , psychotic anxiety disorder History major medical illness ; include asthma chronic obstructive lung disease , history current gastrointestinal ulcer , hepatic renal impairment cardiac rhythm disturbance Use medication include , drug slow heart rate Known allergy galantamine</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>cognitive enhancer</keyword>
	<keyword>Nootropic Agents</keyword>
</DOC>